XML 46 R36.htm IDEA: XBRL DOCUMENT v3.26.3
SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Details Narrative)
3 Months Ended 9 Months Ended
Apr. 17, 2026
USD ($)
Apr. 16, 2026
USD ($)
$ / shares
shares
Jan. 28, 2026
USD ($)
Jan. 27, 2026
USD ($)
$ / shares
shares
Apr. 09, 2025
USD ($)
Sep. 30, 2026
USD ($)
shares
Jun. 30, 2026
shares
Sep. 30, 2025
USD ($)
shares
Mar. 31, 2025
USD ($)
shares
Sep. 30, 2026
USD ($)
shares
Sep. 30, 2025
USD ($)
shares
Jun. 09, 2026
USD ($)
Feb. 06, 2026
USD ($)
Subsidiary, Sale of Stock [Line Items]                          
Aggregate offering price value                 $ 4,244,467        
Issuance of common shares for cash, net of offering costs                   $ 1,291,038 $ 1,636,799    
Legal fees       $ 35,000                  
Clearing agent fee       $ 10,000                  
Fair value of warrant                   (858)    
Legal and other offering-related fees $ 591,085   $ 305,990                    
Proceeds from exercise                   $ 1,523,296 $ 2,009,095    
Issuance of restricted stock awards | shares                   8,497 560    
Restricted stock grant-date fair value                        
Share-Based Payment Arrangement, Option [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Stock based compensation expenses           $ 0   $ 414   $ 276 $ 1,242    
Restricted Stock [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Stock based compensation expenses           52,314   0   $ 69,752 0    
Issuance of restricted stock awards | shares                   92,590      
Restricted stock grant-date fair value                   $ 209,253      
Unamortized stock-based compensation costs           139,501       $ 139,501      
Weighted average period                   8 months 12 days      
Restricted Stock Units (RSUs) [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Stock based compensation expenses           146,232   $ 186,567   $ 342,305 $ 585,847    
Unamortized stock-based compensation costs           $ 1,595,682       $ 1,595,682      
Weighted average period                   3 years      
Common stock vested restricted stock units | shares                   7,331      
Common Stock [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Aggregate offering price value                 $ 1,024        
Issuance of common shares for cash, net of offering costs, shares | shares                 102,444        
Exercise of warrants, shares | shares           540,000 1,950,349 202,083 38,528        
Issuance of restricted stock awards | shares                 1,215        
Restricted stock grant-date fair value                 $ 12        
Common Stock [Member] | Restricted Stock Units (RSUs) [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Common stock vested restricted stock units | shares                   8,880      
Measurement Input, Risk Free Interest Rate [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Warrants and rights outstanding, measurement input 3.9   3.8                    
Measurement Input, Expected Term [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Expected term 5 years 1 month 13 days   5 years                    
Measurement Input, Option Volatility [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Warrants and rights outstanding, measurement input 116.0   116.0                    
Measurement Input, Expected Dividend Payment [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Warrants and rights outstanding, measurement input 0   0                    
Series G Warrant [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Exercise of warrants, shares | shares                   143,380      
Proceeds from exercise                   $ 596,461,000,000      
Series H Warrant [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Exercise of warrants, shares | shares                   222,746      
Proceeds from exercise                   $ 926,623,000,000      
Placement Agent Warrants [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Exercise price | $ / shares       $ 5.5125                  
Percentage of placement agent cash fees gross proceeds       7.00%                  
Management fee percentage       1.00%                  
Warrants issued | shares       23,016                  
Public offering price percentage   125.00%   125.00%                  
Fair value of warrant $ 223,000   $ 63,000                    
Pre-Funded Warrants [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Exercise of warrants, shares | shares                   2,124,223      
Proceeds from exercise                   $ 212      
Private Placement [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Exercise price | $ / shares       $ 4.16                  
Private Placement [Member] | Series G Warrant [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Warrants issued | shares       328,802                  
Private Placement [Member] | Series H Warrant [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Warrants issued | shares       328,802                  
ATM Agreement [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Aggregate offering price value         $ 1,854,151                
Percentage of gross sales price         $ 3                
Arrangement registration payment                       $ 2,425,000 $ 1,346,000
Issuance of common shares for cash, net of offering costs, shares | shares                   497,200      
Issuance of common shares for cash, net of offering costs                   $ 1,291,038      
Remaining amount available to sell           $ 2,425,000       $ 2,425,000      
January 2026 Purchase Agreement [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares issued | shares       328,802                  
Number of shares sold, per shares | $ / shares       $ 4.41                  
Aggregate gross proceeds from offering       $ 1,500,000                  
Securities Purchase Agreement [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Aggregate gross proceeds from offering   $ 5,000,000.0                      
Securities Purchase Agreement [Member] | Common Stock [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares issued | shares   98,000                      
Securities Purchase Agreement [Member] | Pre-Funded Warrants [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares issued | shares   2,124,223                      
Securities Purchase Agreement [Member] | Series I Warrants [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares issued | shares   2,222,223                      
Expected term   5 years                      
Securities Purchase Agreement [Member] | Series J Warrants [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares issued | shares   2,222,223                      
Exercise price | $ / shares   $ 2.00                      
Expected term   18 months                      
Nominal exercise price | $ / shares   $ 0.0001                      
April Placement Agent Warrants [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares issued | shares   155,556                      
Percentage of placement agent cash fees gross proceeds   7.00%                      
Management fee percentage   1.00%                      
April Placement Agent Warrants [Member] | Series I Warrants [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Exercise price | $ / shares   $ 2.8125